 | Berenberg Bank Reaffirms "Buy" Rating for Cue Biopharma (NASDAQ:CUE)
marketbeat.com - March 17 at 7:41 AM |
 | We're Not Very Worried About Cue Biopharma's (NASDAQ:CUE) Cash Burn Rate
finance.yahoo.com - April 9 at 7:51 AM |
 | Analysts Expect Cue Biopharma, Inc. (NASDAQ:CUE) Will Post Quarterly Sales of $480,000.00
americanbankingnews.com - March 28 at 9:46 AM |
| Traders Purchase Large Volume of Cue Biopharma Call Options (NASDAQ:CUE)
americanbankingnews.com - March 25 at 6:38 AM |
| Kenneth Pienta Sells 13,000 Shares of Cue Biopharma, Inc. (NASDAQ:CUE) Stock
americanbankingnews.com - March 17 at 5:10 PM |
| Cue Biopharma (NASDAQ:CUE) Receives Buy Rating from Berenberg Bank
americanbankingnews.com - March 17 at 10:10 AM |
| Cue Biopharma (NASDAQ:CUE) Announces Earnings Results
americanbankingnews.com - March 17 at 9:30 AM |
 | Cue Biopharma, Inc. 2021 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 17 at 5:47 AM |
| Cue Biopharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - March 16 at 7:26 PM |
| Cue Biopharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - March 16 at 7:26 PM |
|
| Cue Biopharma to Present Corporate Overview and Clinical Progress at the Upcoming Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 15 at 12:41 PM |
 | Cue Biopharma earnings preview: what Wall Street is expecting
markets.businessinsider.com - March 14 at 11:38 AM |
| Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference
finance.yahoo.com - March 1 at 9:02 AM |
| Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
finance.yahoo.com - February 25 at 12:08 PM |
| Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
finance.yahoo.com - February 25 at 12:07 PM |
| What Is The Ownership Structure Like For Cue Biopharma, Inc. (NASDAQ:CUE)?
finance.yahoo.com - February 23 at 8:51 AM |
| Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference
markets.businessinsider.com - February 23 at 12:26 AM |
| Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference
finance.yahoo.com - February 22 at 2:25 PM |
| Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development
finance.yahoo.com - February 17 at 9:24 AM |
| Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer
finance.yahoo.com - February 8 at 12:45 PM |
| 7 Stocks With Insider Buying This Week Worth A Look
finance.yahoo.com - February 6 at 7:47 AM |
| How Much Are Cue Biopharma, Inc. (NASDAQ:CUE) Insiders Spending On Buying Shares?
finance.yahoo.com - January 9 at 10:05 AM |
| Is CUE A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 1:29 AM |
| Do Options Traders Know Something About Cue Biopharma (CUE) Stock We Don't?
finance.yahoo.com - December 7 at 6:24 PM |
 | Insider Buying: The Cue Biopharma, Inc. (NASDAQ:CUE) Independent Director Just Bought 3.9% More Shares
nasdaq.com - November 29 at 4:05 PM |
| Cue Biopharma Inc Registered Shs Buy
markets.businessinsider.com - November 25 at 6:53 PM |
| Upgrade: Analysts Just Made A Meaningful Increase To Their Cue Biopharma, Inc. (NASDAQ:CUE) Forecasts
nasdaq.com - November 25 at 8:51 AM |
| News Flash: Analysts Just Made A Substantial Upgrade To Their Cue Biopharma, Inc. (NASDAQ:CUE) Forecasts
finance.yahoo.com - November 25 at 8:51 AM |
|
| Benzinga's Top Upgrades, Downgrades For November 24, 2020
finance.yahoo.com - November 24 at 2:03 PM |
| Cue Biopharma to Present at the Piper Sandler 32nd Annual Healthcare Conference
finance.yahoo.com - November 23 at 12:59 PM |
 | Cue Biopharma PR Shows Q3 EPS $(0.34) Down From $(0.31) YoY, Sales $704.00K Down From $984.00K YoY; Results Were Out Last Week In A Filing
benzinga.com - November 20 at 12:57 AM |
| Cue Biopharma Extends Research Collaboration for the Development of Immuno-STAT Biologics for the Treatment of Defined Autoimmune Diseases with Merck
finance.yahoo.com - November 19 at 9:53 AM |
| Cue Biopharma reports Q3 results, issues update to lead program
seekingalpha.com - November 18 at 12:40 PM |
| Cue Biopharma EPS beats by $0.12, misses on revenue
seekingalpha.com - November 17 at 8:15 PM |
| Cue Biopharma Reports Third Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
finance.yahoo.com - November 17 at 8:15 PM |
| Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
finance.yahoo.com - November 11 at 1:05 PM |
| Cue Biopharma Announces Presentations Highlighting Clinical Progress of CUE-101, Pipeline Progress of CUE-100 Series Immuno-STATs and Immuno-STAT Data for Infectious Disease Applications at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting
finance.yahoo.com - November 9 at 8:47 AM |
| Did Cue Biopharma's (NASDAQ:CUE) Share Price Deserve to Gain 28%?
finance.yahoo.com - November 3 at 9:40 AM |
| Cue Biopharma Inc Registered Shs hosts conference call for investors
markets.businessinsider.com - October 30 at 12:48 PM |
| Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting
benzinga.com - October 19 at 1:28 PM |
| Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting
finance.yahoo.com - October 19 at 8:28 AM |
 | Cue Biopharma Inc
bloomberg.com - October 18 at 5:05 PM |
| Cue Biopharma Announces Nature Methods Publication of Preclinical Data Showing Tumor Penetration and Antigen-Specific T Cell Engagement with Immuno-STAT Based Protein Scaffolds
finance.yahoo.com - September 15 at 12:30 PM |
| Cue Biopharma (CUE) Catches Eye: Stock Jumps 5.2%
finance.yahoo.com - September 10 at 12:51 PM |
| Companies Like Cue Biopharma (NASDAQ:CUE) Are In A Position To Invest In Growth
finance.yahoo.com - September 4 at 10:54 AM |
| Cue Biopharma to Present at Upcoming Investor Conferences in September 2020
finance.yahoo.com - September 3 at 8:59 AM |
| Cue Biopharma, Inc. (CUE) CEO Dan Passeri on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - September 1 at 10:07 AM |
| Cue Biopharma Reports Second Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
finance.yahoo.com - August 31 at 11:58 PM |
| Cue Biopharma EPS beats by $0.05, misses on revenue
seekingalpha.com - August 31 at 6:58 PM |
| Cue Biopharma Reports Second Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
finance.yahoo.com - August 31 at 6:58 PM |
| Cue Biopharma to Present at the 16th Annual PEGS Boston Essential Protein Engineering & Cell Therapy Summit
markets.businessinsider.com - August 24 at 2:21 PM |
